- Home
- AUPH vs SPH Comparison
AUPH vs SPH Comparison
Compare AUPH & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- SPH
- Stock Information
- Founded
- AUPH 1993
- SPH 1945
- Country
- AUPH Canada
- SPH United States
- Employees
- AUPH 300
- SPH N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- SPH Other Specialty Stores
- Sector
- AUPH Health Care
- SPH Consumer Discretionary
- Exchange
- AUPH Nasdaq
- SPH Nasdaq
- Market Cap
- AUPH 1.2B
- SPH 1.2B
- IPO Year
- AUPH 1999
- SPH 1996
- Fundamental
- Price
- AUPH $8.93
- SPH $18.61
- Analyst Decision
- AUPH Strong Buy
- SPH Sell
- Analyst Count
- AUPH 2
- SPH 1
- Target Price
- AUPH $11.50
- SPH $17.00
- AVG Volume (30 Days)
- AUPH 2.1M
- SPH 93.7K
- Earning Date
- AUPH 07-31-2025
- SPH 08-07-2025
- Dividend Yield
- AUPH N/A
- SPH 7.00%
- EPS Growth
- AUPH N/A
- SPH N/A
- EPS
- AUPH 0.27
- SPH 1.46
- Revenue
- AUPH $247,295,000.00
- SPH $1,424,243,000.00
- Revenue This Year
- AUPH $12.15
- SPH $10.99
- Revenue Next Year
- AUPH $18.34
- SPH N/A
- P/E Ratio
- AUPH $33.57
- SPH $12.73
- Revenue Growth
- AUPH 29.20
- SPH 4.02
- 52 Week Low
- AUPH $5.20
- SPH $15.20
- 52 Week High
- AUPH $10.67
- SPH $22.24
- Technical
- Relative Strength Index (RSI)
- AUPH 57.25
- SPH 52.18
- Support Level
- AUPH $8.73
- SPH $18.20
- Resistance Level
- AUPH $9.37
- SPH $18.69
- Average True Range (ATR)
- AUPH 0.41
- SPH 0.28
- MACD
- AUPH 0.04
- SPH 0.04
- Stochastic Oscillator
- AUPH 77.28
- SPH 84.85
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.